|
1
|
A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.
|
Cell
|
2007
|
5.85
|
|
2
|
Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury.
|
Circ Res
|
2004
|
2.45
|
|
3
|
Postpartum cardiomyopathy: a cardiac emergency for gynecologists, general practitioners, internists, pulmonologists, and cardiologists.
|
Dtsch Arztebl Int
|
2008
|
1.75
|
|
4
|
Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine.
|
J Am Coll Cardiol
|
2007
|
1.63
|
|
5
|
Regulation of proangiogenic factor CCN1 in cardiac muscle: impact of ischemia, pressure overload, and neurohumoral activation.
|
Circulation
|
2004
|
1.13
|
|
6
|
Role of interleukin-6 for LV remodeling and survival after experimental myocardial infarction.
|
FASEB J
|
2003
|
1.05
|
|
7
|
16-kDa prolactin and bromocriptine in postpartum cardiomyopathy.
|
Curr Heart Fail Rep
|
2012
|
0.83
|
|
8
|
Bromocriptine treatment associated with recovery from peripartum cardiomyopathy in siblings: two case reports.
|
J Med Case Rep
|
2010
|
0.80
|
|
9
|
Cardiovascular disorders in pregnancy: diagnosis and management.
|
Best Pract Res Clin Obstet Gynaecol
|
2013
|
0.78
|
|
10
|
Prognostic value of NT-proBNP in patients with systemic morphological right ventricles: a single-centre experience.
|
Int J Cardiol
|
2013
|
0.75
|